79 related articles for article (PubMed ID: 23160683)
1. In search of new biological activities of isolates from Odontoglossum Harvengtense 'Tutu'.
Suzuki R; Tanaka T; Yamamoto M; Sakagami H; Tomomura M; Tomomura A; Satoh K; Shirataki Y
In Vivo; 2012; 26(6):993-9. PubMed ID: 23160683
[TBL] [Abstract][Full Text] [Related]
2. Diverse biological activity of Odontoglossum Harvengtense 'Tutu' bulb extracts.
Masuda Y; Ueda JY; Tamura M; Sakagami H; Tomomura M; Tomomura A; Shirataki Y
In Vivo; 2011; 25(3):381-6. PubMed ID: 21576411
[TBL] [Abstract][Full Text] [Related]
3. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
4. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators.
Bu SY; Lerner M; Stoecker BJ; Boldrin E; Brackett DJ; Lucas EA; Smith BJ
Calcif Tissue Int; 2008 Jun; 82(6):475-88. PubMed ID: 18509698
[TBL] [Abstract][Full Text] [Related]
5. Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.
Cheng CP; Sheu MJ; Sytwu HK; Chang DM
Rheumatology (Oxford); 2013 Apr; 52(4):609-22. PubMed ID: 23221330
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide FF attenuates RANKL-induced differentiation of macrophage-like cells into osteoclast-like cells.
Sun Y; Chen X; Chen Z; Ma X; Li D; Shang P; Qian A
Arch Oral Biol; 2015 Feb; 60(2):282-92. PubMed ID: 25463906
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.
Ang ES; Pavlos NJ; Chai LY; Qi M; Cheng TS; Steer JH; Joyce DA; Zheng MH; Xu J
J Cell Physiol; 2009 Dec; 221(3):642-9. PubMed ID: 19681045
[TBL] [Abstract][Full Text] [Related]
9. Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor kappaB ligand-induced osteoclast differentiation of murine marcophages.
Hung CJ; Kao CT; Chen YJ; Shie MY; Huang TH
J Endod; 2013 Dec; 39(12):1557-61. PubMed ID: 24238446
[TBL] [Abstract][Full Text] [Related]
10. Pilot clinical study of Sasa senanensis Rehder leaf extract treatment on lichenoid dysplasia.
Matsuta T; Sakagami H; Tanaka S; Machino M; Tomomura M; Tomomura A; Yasui T; Itoh K; Sugiura T; Kitajima M; Oizumi H; Oizumi T
In Vivo; 2012; 26(6):957-62. PubMed ID: 23160678
[TBL] [Abstract][Full Text] [Related]
11. New biological activities of Rhinacanthins from the root of Rhinacanthus nasutus.
Horii H; Suzuki R; Sakagami H; Tomomura M; Tomomura A; Shirataki Y
Anticancer Res; 2013 Feb; 33(2):453-9. PubMed ID: 23393336
[TBL] [Abstract][Full Text] [Related]
12. Two new naphthalene glucosides and other bioactive compounds from the carnivorous plant Nepenthes mirabilis.
Thanh NV; Thao NP; Dat le D; Huong PT; Lee SH; Jang HD; Cuong NX; Nam NH; Kiem PV; Minh CV; Kim YH
Arch Pharm Res; 2015 Oct; 38(10):1774-82. PubMed ID: 25724283
[TBL] [Abstract][Full Text] [Related]
13. CpG oligonucleotides: novel regulators of osteoclast differentiation.
Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z
FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977
[TBL] [Abstract][Full Text] [Related]
14. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor-2 selective antagonist negatively regulates receptor activator of nuclear factor kappa B ligand mediated osteoclastogenesis.
Geng DC; Xu YZ; Yang HL; Zhu GM; Wang XB; Zhu XS
Chin Med J (Engl); 2011 Feb; 124(4):586-90. PubMed ID: 21362286
[TBL] [Abstract][Full Text] [Related]
16. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation.
Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y
J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961
[TBL] [Abstract][Full Text] [Related]
17. Effect of two different groups of Chinese medicines on nitric oxide production by mouse macrophage-like cells.
Kaneko T; Chiba H; Horie N; Hashimoto K; Satoh K; Kusama K; Sakagami H
In Vivo; 2004; 18(6):771-8. PubMed ID: 15646819
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.
Nilforoushan D; Gramoun A; Glogauer M; Manolson MF
Nitric Oxide; 2009 Aug; 21(1):27-36. PubMed ID: 19389479
[TBL] [Abstract][Full Text] [Related]
19. 9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1.
Kim JY; Kim JY; Cheon YH; Kwak SC; Baek JM; Kim YC; Yoon KH; Oh J; Lee MS
Int Immunopharmacol; 2014 May; 20(1):213-20. PubMed ID: 24630975
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
